Home » Business, Food & Beverage, Manufacturing & Industry » Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market To Gain From Enhanced Demand In End-use Industries Till 2024: Grand View Research, Inc.
“Grand View Research, Inc. – Market Research And Consulting.”
According to report published by Grand View Research, global Omega 3 PUFA (Poly Unsaturated Fatty Acid) is a kind of necessary fats which cannot be produced by human body and which imposes ingestion through food, as it is a primary source for enhancing metabolic processes such as cognitive and cardiovascular functions.

Omega 3 PUFA (Poly Unsaturated Fatty Acid) is a kind of necessary fats which cannot be produced by human body and which imposes ingestion through food, as it is a primary source for enhancing metabolic processes such as cognitive and cardiovascular functions. Omega 3 PUFA has come out as possible nutritional ingredients. Its use in equipped food products, supplements, nutritive drinks, and pharmaceuticals will be a crucial factor for growth over the forecast period. Omega 3 PUFA ingredients have been acquiring high traction in the food & beverage industry with the thriving equipped products sections. The consumer consciousness of the product’s health advantage and growing disposable income, particularly in urban sections of society, will direct the expansion over the forecast period.

Full research report on Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Analysis: http://www.grandviewresearch.com/industry-analysis/omega-3-polyunsaturated-fatty-acids-pufas-market

The demand has been increasing and is expected to continue growing significantly over the forecast period. Many factors are supposed to influence the industry over the forecast period such as the prevalence of fish oil in the world market for omega-3. For one, the industry is meant to witness a marked shift directed towards products with superior concentrations which will be a key trend in the future. It results in the consumers upgrading from lesser concentrated products to more concentrated products for a purpose to get more DHA/EPA per capsule. Products with high concentrations provide the benefit of attaining the related health-promoting levels of DHA (Docosahexaenoic Acid) and EPA(Eicosapentaenoic Acid). Pharmaceutical drugs, by evasion, have initialized incorporating more concentrations of the product, and it is expected that over the forecast period, several different companies would be hopping on to the production of omega-3 drugs. Several other drugs are in Phase III or Phase II clinical trials, with much more expected to come on-stream pretty soon. Moreover, the coming year or two it is anticipated that an influx of innovative companies is entering this sector.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

In a global scenario where growing attention is being focussed towards the matter of limited food supplies and sustainability, algal sources provide tremendous scope for the quickly expanding industry to carry on in the same vein. The focus on attaining DHA (Docosahexaenoic Acid) and EPA (Eicosapentaenoic Acid) from algae was encouraged by an endeavor to search for more sustainable sources. However, the omega-3 content in krill and fish originates from their excessive consumption of other creatures that nourish on algae directly. The past decades have witnessed many research studies that have underlined the importance of omega-3 PUFA in keeping good heart health. In addition, to protection against cancer and birth deficiencies and counteract symptoms of arthritis, diabetes, depression, cognitive decline and many other conditions. Omega-3 polyunsaturated fatty acid has been increasing in consumption and continues to grow considerably over the forecast period, attributing to the benefits as mentioned earlier.

The market has been segmented by type mainly into Omega 3 ingredients comprising Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA). EPA and DHA account for a significant share in terms of revenue, owing to their increasing application in products that decreases the possibility of cardiovascular diseases. On the basis of various sources, the market can be segregated into sardines/anchovy, salmon, plant, menhaden, seed, krill, nut, cod, and tuna. Nut, Plant, and seed are expected to capture maximum revenue over the forecast period owing to increasing demand for marine extracted omega-3 coupled with growing inclination towards plant supported diet. On the basis of application, the market can be segregated into fat & spreads, dairy products & eggs food supplements, bakery, confectionary, dietary supplements and non-alcoholic beverages.

Read Our Blogs – grandviewresearch.com/blogs/food-and-beverages 

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information : www.grandviewresearch.com 

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: sales@grandviewresearch.com
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/omega-3-polyunsaturated-fatty-acids-pufas-market

Comments are closed.